Cargando…

Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer

Prostate-specific antigen (PSA) testing has been widely used to screen men for prostate cancer (PCa) and to monitor PCa progression. However, more studies have shown that around 15% of men with low or normal PSA levels have PCa. In this study, we aimed to investigate the relationship of androgen and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Weitao, Soni, Vikram, Khera, Mohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577595/ https://www.ncbi.nlm.nih.gov/pubmed/25761834 http://dx.doi.org/10.4103/1008-682X.148721

Ejemplares similares

Testosterone inhibits the growth of prostate cancer xenografts in nude mice
por: Song, Weitao, et al.
Publicado: (2017)

Testosterone therapy and prostate cancer
por: Pastuszak, Alexander W., et al.
Publicado: (2016)

AB12. Testosterone and prostate cancer: adding fuel to the fire?
por: Khera, Mohit
Publicado: (2014)

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
por: Pastuszak, Alexander W, et al.
Publicado: (2015)

Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro
por: Song, Weitao, et al.
Publicado: (2014)

Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
por: Sachdev, Saachi, et al.
Publicado: (2020)

Prostate-Specific Antigen and Testosterone Levels as Biochemical Indicators of Cognitive Function in Prostate Cancer Survivors and the Role of Diabetes
por: Popiołek, Alicja, et al.
Publicado: (2021)

Prostate specific antigen and relative prostate weight data on effect of Tetracarpidium conophorum leaf extract on testosterone-induced benign prostatic hyperplasia
por: Omotosho, Omolola E., et al.
Publicado: (2018)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
por: Kusuma Duarsa, Gede Wirya, et al.
Publicado: (2021)

Do prostate-specific antigen parameters have a similar role in predicting prostate cancer regardless of serum testosterone levels in men with gray-zone prostate-specific antigen levels?
por: Oh, Jeong Hoon, et al.
Publicado: (2022)

Controversies in testosterone supplementation therapy
por: Khera, Mohit
Publicado: (2015)

Clinical value of prostate-specific antigen combined with tumor abnormal protein (TAP) in the diagnosis of prostate puncture
por: Guan, Yu, et al.
Publicado: (2020)

Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer
por: Wang, Xijuan, et al.
Publicado: (2017)

SUN-223 Impact of Testosterone Replacement Therapy (TRT) on Prostate Specific Antigen (PSA) in Patients with Clinical Evidence of Prostate Hyperplasia
por: Subramaniam, Shreya, et al.
Publicado: (2019)

Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific Antigen
por: Lee, Dong Kil, et al.
Publicado: (2010)

Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
por: Sauter, Edward R, et al.
Publicado: (2002)

Is There an Association Between Serum Prostate-Specific Antigen Values and Serum Testosterone Levels in Healthy Men?
por: Mustafa, Mahmoud, et al.
Publicado: (2014)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
por: Raju, Govinda Nanjaiah Laxmana, et al.
Publicado: (2022)

The era of prostate-specific membrane antigen for the diagnosis and treatment of prostate cancer: A novel horizon
por: Song, Byeongdo, et al.
Publicado: (2023)

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
por: Gilbert, Rebecca, et al.
Publicado: (2018)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer
por: Nepal, Sat Prasad, et al.
Publicado: (2023)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
por: Kim, Jun Seok, et al.
Publicado: (2015)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

Testosterone’s Role in COVID-19
por: Auerbach, Jeremy M., et al.
Publicado: (2021)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Correlation Between Serum Prostate-Specific Antigen and Testosterone Following Bilateral Total Orchidectomy for Patients with Advanced Prostate Cancer in Jos, Nigeria
por: Osunaiye, Olutayo Israel, et al.
Publicado: (2023)

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer
por: Zhang, Qingxu, et al.
Publicado: (2023)

Prostate specific antigen /
Publicado: (2001)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
por: Bai, Xiaojing, et al.
Publicado: (2020)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
por: Javaeed, Arslaan, et al.
Publicado: (2020)

Prostate-specific antigen testing accuracy in community practice
por: Hoffman, Richard M, et al.
Publicado: (2002)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

A prospective study of the effect of testosterone escape on preradiotherapy prostate-specific antigen kinetics in prostate cancer patients undergoing neoadjuvant androgen deprivation therapy
por: Christie, David R.H., et al.
Publicado: (2021)

Point-of-Care Prostate Specific Antigen Testing: Examining Translational Progress toward Clinical Implementation
por: Garg, Saweta, et al.
Publicado: (2023)

Utility of Free/Total Prostate Specific Antigen (f/t PSA) Ratio in Diagnosis of Prostate Carcinoma
por: Thakur, V., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_te3uk45v9dfc521i160j4erhrq